GLIOBLASTOMA, IDH-WILDTYPE
Clinical trials for GLIOBLASTOMA, IDH-WILDTYPE explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA, IDH-WILDTYPE trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA, IDH-WILDTYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Two-Drug attack on tough brain cancers
Disease control Not yet recruitingThis study is testing a new combination of two drugs, retifanlimab and DFMO, for people with aggressive brain tumors (high-grade gliomas) that have started growing again. The main goals are to find the safest dose of DFMO to use with retifanlimab and to see if the combination cha…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New pulsed radiation offers hope for brain cancer patients to live longer, think clearer
Disease control Not yet recruitingThis study is for adults newly diagnosed with a specific, aggressive type of brain tumor called MGMT-unmethylated glioblastoma. It compares a new way of delivering radiation, called Temporally-Modulated Pulsed Radiation Therapy (TMPRT), against the current standard radiation. Bot…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Mar 12, 2026 13:50 UTC